73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Inogen Inc
Closed
SectorHealthcare
6.1 5.9
Overview
Share price change
24h
Min
5.49
Max
6.15
Income | -1.1M -5.3M |
|---|---|
Sales | 113K 92M |
Profit margin | -5.73 |
Employees | 766 |
EBITDA | 5.9M -221K |
Recommendations | Buy |
|---|---|
12 Months Forecast | +132.56% upside |
Next Earnings | 24 Feb 2026 |
|---|
Market Cap | -70M 152M |
|---|---|
Previous open | 0.2 |
Previous close | 6.1 |
News Sentiment
By Acuity
26%
74%
53 / 352 Healthcare
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Inogen Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Inogen Inc Forecast
Price Target
By TipRanks
132.56% upside
12 Months Forecast
Average 13 USD 132.56%
High 14 USD
Low 12 USD
Based on 2 Wall Street analysts offering 12 month price targets forInogen Inc - Dist in the last 3 months.
Sentiment
By Acuity
53 / 352 Healthcare
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Live chat